Michael Wolinski
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $445.02 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $217.21 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $86.29 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $53.25 | 3 | $0 (2024) |
| ABIOMED | $33.46 | 1 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $28.19 | 1 | $0 (2024) |
| PFIZER INC. | $26.62 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $445.02 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($217.21) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.74 | General |
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: Genetic Disease | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $86.29 | General |
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
About Michael Wolinski
Michael Wolinski is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bannockburn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2024. The National Provider Identifier (NPI) number assigned to this provider is 1013776673.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Wolinski has received a total of $445.02 in payments from pharmaceutical and medical device companies, with $445.02 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($445.02).
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Physician Assistant
- Location Bannockburn, IL
- Active Since 03/18/2024
- Last Updated 08/01/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013776673
Products in Payments
- JARDIANCE (Drug) $100.47
- FARXIGA (Drug) $34.68
- Impella (Device) $33.46
- ONPATTRO (Drug) $28.19
- VYNDAQEL (Drug) $26.62
- WAINUA (Drug) $18.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.